Dostarlimab | FDA Orange Book | Approved Drug Product List | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Dostarlimab
FDA Orange Book

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Dostarlimab

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

FINISHED DOSAGE FORMULATIONS

8 FDF Dossiers, 2 FDA Orange Book, 1 Europe, 1 Canada, 4 Australia

8 FDF Dossiers
2 FDA Orange Book
1 Europe
1 Canada
4 Australia

DIGITAL CONTENT

2 STOCK RECAP #PipelineProspector, 45 NEWS #PharmaBuzz

2 STOCK RECAP #PipelineProspector
45 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 Finished Drug Prices, 3 Annual Reports

1 Finished Drug Prices
3 Annual Reports

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

2 All

01 1GLAXOSMITHKLINE

02 1GLAXOSMITHKLINE LLC

filter Dosage Reset all filters

2 All

01 2INJECTABLE;INJECTION

filter Regulatory Info Reset all filters

2 All

01 2Blank

filter Brand Name Reset all filters

2 All

01 2JEMPERLI

filter RLD Reset all filters

2 All

01 2Blank

List of Suppliers

Product Main Page

01

GLAXOSMITHKLINE

2024 ACI Convention

Not Confirmed

GLAXOSMITHKLINE

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

DOSTARLIMAB-GXLY

Brand Name : JEMPERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/10ML

Approval Date :

Application Number : 761174

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

GLAXOSMITHKLINE LLC

2024 ACI Convention

Not Confirmed

GLAXOSMITHKLINE LLC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD :

TE Code :

DOSTARLIMAB-GXLY

Brand Name : JEMPERLI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 500MG/10ML

Approval Date :

Application Number : 761223

RX/OTC/DISCN :

RLD :

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?